Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 6/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 6/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL7994351 | 1.00 | CHRNB2 (0.44) | CHRNB2CHRNA3CHRM2CHRM4CHRM5 | |
| Oxalic Acid SCHEMBL7414834 | 0.92 | CHRNB2 (0.44) | CHRNB2CHRNA3CHRM2CHRM4CHRM5 | |
| Oxalic Acid SCHEMBL7423054 | 0.92 | CHRNB2 (0.44) | CHRNB2CHRNA3CHRM2CHRM4CHRM5 | |
| SCHEMBL7472477 | 0.92 | CHRNB2 (0.48) | CHRNB2CHRNA3 | |
| SCHEMBL7472472 | 0.92 | CHRNB2 (0.48) | CHRNB2CHRNA3 | |
| Oxalic Acid SCHEMBL8009465 | 0.84 | CHRNB2 (0.43) | CHRNB2CHRNA3CHRM2CHRM4CHRM5 | |
| SCHEMBL7423822 | 0.84 | CHRNB2 (0.50) | CHRNB2CHRNA3CHRM3 | |
| SCHEMBL7423827 | 0.84 | CHRNB2 (0.50) | CHRNB2CHRNA3CHRM3 | |
| SCHEMBL7994340 | 0.75 | CHRNB2 (0.49) | CHRNB2CHRNA3 | |
| Oxalic Acid SCHEMBL8842149 | 0.70 | CHRNB2 (0.85) | CHRNB2CHRNA3CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6022868-A | TREATING DISEASES IN THE CENTRAL NERVOUS SYSTEM RELATED TO MALFUNCTIONING OF THE NICOTINIC CHOLINERGIC SYSTEM. | NOVO NORDISK ALS (DK) | 2000-02-08 | — | — | US | disclosed |